Acute coronary syndromes in Europe: 1-year costs and outcomes.
作者： Matthew J. Taylor , Paul A. Scuffham , Patrick L. McCollam , David E. Newby
关键词: Incidence (epidemiology) 、 Total cost 、 Severity of illness 、 Cause of death 、 Angina 、 Unstable angina 、 Myocardial infarction 、 Intensive care medicine 、 Myocardial infarction diagnosis 、 Medicine
摘要: ABSTRACTObjective: This study aims to estimate costs (including medications prescribed, intervention rates and hospital utilization) health outcomes of acute coronary syndromes (ACS) during the first year following diagnosis.Research design methods: Treatment pathways for ACS patients were developed country-specific resource use was multiplied by unit costs. Countries examined United Kingdom (UK), France, Germany, Italy Spain. Patients with unstable angina myocardial infarction (ST-segment elevation non-ST-segment with/without Q-wave) considered. The models incidence ACS, 1-year mortality, investigations, revascularisation, pharmaceutical medical management. Economic direct healthcare (in 2004 Euros), including total cost, cost per patient capita.Results: estimated number deaths in diagnosis ranged from around 22 500 Spain over 90 000 Germany. Th...
sci-hub.se 参考文章(27)
A. I. González González, Alberto Blasco Lobo, Lorenzo Silva Melchor, José María Lobos Bejarano, Tratamiento médico de la angina estable: Fármacos antianginosos y prevención secundaria de la cardiopatía isquémica Información terapéutica del Sistema Nacional de Salud. ,vol. 27, pp. 33- 56 ,(2003)
S J Maynard, Management of acute coronary syndromes BMJ. ,vol. 321, pp. 220- 223 ,(2000) , 10.1136/BMJ.321.7255.220
OECD Study of Cross-National Differences in the Treatment, Costs and Outcomes of Ischaemic Heart Disease Research Papers in Economics. ,(2003) , 10.1787/230112362071
A.P. Netten, Lesley A. Curtis, Unit Costs of Health and Social Care 2002 Personal Social Services Research Unit. ,(2002)
Bruno Detournay, Xavier Huet, Fran??ois Fagnani, Gilles Montalescot, Economic evaluation of enoxaparin sodium versus heparin in unstable angina. A French sub-study of the ESSENCE trial. PharmacoEconomics. ,vol. 18, pp. 83- 89 ,(2000) , 10.2165/00019053-200018010-00009
Adalsteinn I.D. Brown, Alan M. Garber, A CONCISE REVIEW OF THE COST-EFFECTIVENESS OF CORONARY HEART DISEASE PREVENTION Medical Clinics of North America. ,vol. 84, pp. 279- 297 ,(2000) , 10.1016/S0025-7125(05)70219-4
Philippe Gabriel Steg, Robert J Goldberg, Joel M Gore, Keith AA Fox, Kim A Eagle, Marcus D Flather, Immad Sadiq, Rachel Kasper, Sophie K Rushton-Mellor, Frederick A Anderson, GRACE Investigators, Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). American Journal of Cardiology. ,vol. 90, pp. 358- 363 ,(2002) , 10.1016/S0002-9149(02)02489-X
Lee Goldman, Kathryn A Phillips, Pamela Coxson, Paula A Goldman, Lawrence Williams, M.G.Myriam Hunink, Milton C Weinstein, The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost Journal of the American College of Cardiology. ,vol. 38, pp. 1012- 1017 ,(2001) , 10.1016/S0735-1097(01)01512-1
Glenn Salkeld, Philayrath Phongsavan, Brian Oldenburg, Magnus Johannesson, Paula Convery, Peita Graham-Clarke, Sheila Walker, John Shaw, The cost-effectiveness of a cardiovascular risk reduction program in general practice Health Policy. ,vol. 41, pp. 105- 119 ,(1997) , 10.1016/S0168-8510(97)00015-8
James Lightwood, The economics of smoking and cardiovascular disease. Progress in Cardiovascular Diseases. ,vol. 46, pp. 39- 78 ,(2003) , 10.1016/S0033-0620(03)00077-X